General Statement of Disclosure:

CONSULTING FEES/HONORARIA: New Amsterdam Pharma(MODEST) RESEARCH/RESEARCH GRANTS: Novartis Corporation(SIGNIFICANT), Amgen Inc.(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Esperion(SIGNIFICANT)

View Full Disclosure